ImageneBio (IMA) Revenue (2020 - 2025)

ImageneBio has disclosed Revenue across 6 years of filings, most recently posting $800000.0 for Q1 2025.

• In Q1 2025, Revenue changed N/A year-over-year to $800000.0; the TTM figure through Sep 2025 stood at $4.3 million (down 41.48% YoY), while the FY2023 annual figure was $9.2 million, down 41.35% from the prior year.
• Revenue came in at $800000.0 for Q1 2025 at ImageneBio, down from $3.5 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $20.2 million in Q4 2021 to a low of $382000.0 in Q2 2022.
• Average Revenue over 5 years is $4.3 million, with a median of $3.5 million recorded in 2021.
• Year-over-year, Revenue soared 31003.08% in 2021 and slumped 89.24% in 2022.
• Over 5 years, Revenue stood at $20.2 million in 2021, then plunged by 73.04% to $5.4 million in 2022, then plunged by 87.91% to $659000.0 in 2023, then surged by 431.11% to $3.5 million in 2024, then tumbled by 77.14% to $800000.0 in 2025.
• Per Business Quant data, the three most recent Revenue figures were $800000.0 in Q1 2025, $3.5 million in Q3 2024, and $659000.0 in Q4 2023.